Patients have been reporting multiple ill health effects linked to exposures to mold. Studies of more than 1600 patients suffering ill effects associated with fungal exposure were presented at one meeting in Dallas in 2003 (21st Annual Symposium of Man and His Environment, Dallas, Texas, 19–22 June 2003) .To cite a few studies: Lieberman examined 48 heavily mold-exposed patients who had the following health problems: muscle and/or joint pain (71%), fatigue/weakness (70%), neurocognitive dysfunction (67%), sinusitis (65%), headache (65%), gastrointestinal problems (58%), shortness of breath (54%), anxiety/depression/irritability (54%), vision problems (42%), chest tightness (42%), insomnia (40%), dizziness (38%), numbness/tingling (35%), laryngitis (35%), nausea (33%), skin rashes (27%), tremors (25%) and heart palpitations (21%). Rea et al.’s study of 150 heavily indoor mold-exposed patients found the following health problems: fatigue (100%), rhinitis (65%), memory loss and other neuropsychiatric problems (46%), respiratory problems (40%), fibromyalgia (29%), irritablebowel syndrome (25%), vasculitis (4.7%) and angioedema (4.0%). These clinical reports suggest that there can be multisystem adverse effects of airborne mold. All reported cases had environmental mold exposure consistent with toxic mold exposure.